Researchers have made a discovery that could make therapeutic insulins more effective by better mimicking the way insulin works in the body. The findings could improve treatments for diabetes, a disease that impacts the lives of millions of people worldwide.
Published in Nature Communications, the study reveals the first definitive 3D image of how insulin successfully interacts with its receptor - a 'gatekeeper' for transmitting information into cells - in a process that is crucial for instructing cells to lower blood sugar levels in the body. Understanding exactly what this process looks like could inform the design of faster-acting and longer-lasting insulin therapies.
The researchers produced the first 3D image of how insulin binds to its receptor on the surface of cells in order to instruct the uptake of sugar from the blood.
The cryo-electron microscopy structure of a single insulin bound to a physiologically relevant, high-affinity version of the receptor ectodomain, the latter generated through attachment of C-terminal leucine zipper elements to overcome the conformational flexibility associated with ectodomain truncation.
The resolution of the cryo-electron microscopy maps is 3.2 Å in the insulin-binding region and 4.2 Å in the membrane-proximal region. The structure reveals how the membrane proximal domains of the receptor come together to effect signalling and how insulin’s negative cooperativity of binding likely arises.
"We knew that insulin underwent a physical change that signalled its successful connection with its receptor on the cell surface. But we had never before seen the detailed changes that occurred in the receptor itself, confirming that insulin had successfully delivered the message for the cell to take up sugar from the blood.
"We then combined more than 700,000 of these 2D images into a high-resolution 3D image showing precisely what the successful binding between insulin and its receptor looks like. And there it was before our eyes, the full picture in exquisite detail.
https://www.wehi.edu.au/news/insulin-discovery-game-changer-improving-diabetes-treatments
https://www.nature.com/articles/s41467-018-06826-6
Latest News
Gut bacteria may eliminate pathogens by competing for energy resources
How deep brain stimulation treats Parkinson's disease symptoms
Plasma membrane phospholipid plays a key role in epithelial cell adhesion
COVID-19, MIS-C and Kawasaki disease share same immune response
Improved cognition and mood by inducing neurogenesis via optogenetic stimulation of the brain
Other Top Stories
Researchers reveal type of vaginal bacteria that protects women from HIV
Antibiotic resistance in tuberculosis bacterium
An adaptor hierarchy regulates proteolysis during a bacterial cell cycle
Detecting HIV diagnostic antibodies with DNA nanomachines
Th17 cell induction by adhesion of microbes to intestinal epithelial cells
Protocols
Integrating neuroimaging and gene expression data using the imaging transcriptomics toolbox
Antibody structure prediction using interpretable deep learning
A semi-automated workflow for brain Slice Histology Alignment, Registration, and Cell Quantificat…
NanoDam identifies Homeobrain (ARX) and Scarecrow (NKX2.1) as conserved temporal factors in the D…
Spatiotemporal transcriptomic atlas of mouse organogenesis using DNA nanoball-patterned arrays
Publications
FMRP regulates GABAA receptor channel activity to control signal integration in hippocampal granu…
Host cells subdivide nutrient niches into discrete biogeographical microhabitats for gut microbes
Intestinal epithelial cell metabolism at the interface of microbial dysbiosis and tissue injury
Maturation of beta cells: lessons from in vivo and in vitro models
Plasma membrane phosphatidylinositol (4,5)-bisphosphate is critical for determination of epitheli…
Presentations
Hydrogels in Drug Delivery
Lipids
Cell biology of carbohydrate metabolism
RNA interference (RNAi)
RNA structure and functions
Posters
ASCO-2020-HEALTH SERVICES RESEARCH AND QUALITY IMPROVEMENT
ASCO-2020-HEAD AND NECK CANCER
ASCO-2020-GENITOURINARY CANCER–KIDNEY AND BLADDER
ASCO-2020-GENITOURINARY CANCER–PROSTATE, TESTICULAR, AND PENILE
ASCO-2020-GYNECOLOGIC CANCER